Keywords: Emergent BioSolutions, BioThrax, Government contract, Anthrax

Emergent BioSolutions gets $1.25 billion BioThrax order for US government

Article | 04 October 2011

Print This

Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government with 44.75 million doses ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in